EDIT- Editas Medicine, Inc.

Name: Editas Medicine, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Editas Medicine, Inc. (EDIT) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	O'Neill Gilmore Neil	269.1K	$780.4K	-
VP	Burkly Linda	68.8K	$199.5K	-
Dir	Connaughton Bernadette	37.5K	$108.8K	-
Dir	Levy Elliott M.	37.5K	$108.8K	-
Dir	Hirsch Andrew	37.5K	$108.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 9, 2022	Eaton Bruce80	EVP, Chief Business Officer	Sell	293	$18.60	$5,449.39	-0.4%	-38.6%	-50.9%
Jun 15, 2022	Shearman Mark S	EVP, Chief Scientific Officer	Sell	5,145	$10.06	$51,744.81	-7.0%	+40.7%	-11.9%
Jun 3, 2022	Eaton Bruce80	EVP, Chief Business Officer	Sell	1,123	$11.54	$12,955.94	-1.7%	+29.5%	-18.8%
Jun 3, 2022	Robertson Michelle75	EVP, Chief Financial Officer	Sell	1,527	$11.54	$17,616.85	-1.8%	+29.5%	-18.8%
May 9, 2022	Eaton Bruce80	EVP, Chief Business Officer	Sell	297	$13.11	$3,894.50	-0.4%	+72.2%	-7.5%
Apr 1, 2022	Eaton Bruce80	EVP, Chief Business Officer	Sell	1,545	$26.61	$41,115.16	-1.1%	-41.5%	-64.1%
Mar 3, 2022	Eaton Bruce80	EVP, Chief Business Officer	Sell	403	$17.33	$6,983.06	-0.6%	-34.5%	-46.5%
Mar 3, 2022	Robertson Michelle75	EVP, Chief Financial Officer	Sell	767	$17.33	$13,290.35	-0.9%	-34.5%	-46.5%
Feb 8, 2022	Eaton Bruce80	EVP, Chief Business Officer	Sell	302	$17.63	$5,323.08	-1.0%	-36.3%	-40.7%
Jan 11, 2022	Robertson Michelle75	Chief Financial Officer	Sell	1,744	$25.70	$44,820.80	-5.3%	-31.8%	-66.9%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC